• How can gene testing results identify the best psychotropic medications for specific people?
    GeneSight analyzes certain genes and predicts their combined influence on each patient's response to psychotropic medications. That helps identify the right medication options for patients to improve outcomes.
  • Can gene testing improve depression treatment?
    GeneSight has shown clinical utility in treating treatment-resistant depression. Clinical studies from primary care and psychiatric care demonstrate a 50% improvement in remission and a 30% improvement in response. The GeneSight Psychotropic test analyzes how genes may affect outcomes with medications commonly prescribed to treat depression, anxiety, ADHD, and other mental health conditions.
  • Should I get gene testing if I am planning to become pregnant?
    Noninvasive prenatal screening can identify your risks for passing down an inherited condition such as cystic fibrosis or spinal muscular atrophy to your baby. Planning for your future family now provides the opportunity to understand potential genetic risks.
  • What type of gene testing does Myriad offer for women’s health?
    Myriad offers three different categories of testing for women: cancer risk assessment with MyRisk, inherited conditions for family planning with ForeSight, and prenatal screening with Prequel.
  • What does Prolaris test for?
    The Prolaris test from Myriad Genetics gives a personalized risk assessment of a patients’ prostate cancer. Prolaris gives the complete picture on how a patient’s prostate cancer will progress by adding clinically proven information in combination with traditional diagnostic tools.
  • How early can Prequel Prenatal Screen be used to identify increased risk for conditions like Down Syndrome?
    Patients can use Prequel as early as ten weeks into their pregnancy to identify an increased risk for a chromosome abnormality associated with a certain genetic condition.
  • What is HRD status?
    Homologous recombination (HR) is the way our body fixes damaged DNA. When homologous recombination is not able to fix damaged DNA, this is called homologous recombination deficiency (HRD). Approximately 50% of all ovarian cancer tumors have homologous recombination deficiency.
  • What is MyChoice CDx?
    MyChoice CDx is the first and only FDA-approved tumor test that determines HRD status using BRCA status and Genomic Instability Status. It is the most comprehensive tumor test to determine HRD status in patients with ovarian cancer.
  • How can BRACAnalysis CDx help my patients?
    BRACAnalysis CDx provides fast and accurate BRCA1/2 results. Germline BRCA1 and BRCA2 status is a critical biomarker to help you determine the appropriate therapy for your patients with breast, ovarian, pancreatic, and prostate cancer.
  • What does BRACAnalysis CDx test for?
    BRACAnaysis CDx is the only FDA-targeted therapy used to detect mutations in BRCA1 or BRCA2 genes. Mutations in these genes can influence breast cancer, ovarian cancer, pancreatic cancer, and prostate cancer. Early detection can help you and your healthcare provider the best healthcare decisions for your future care.
  • What is BRCA?
    Everyone is born with BRCA genes. Normally, the proteins produced by the BRCA1 and BRCA2 genes prevent cells from developing into cancer. When one of these genes becomes ineffective due to an inherited mutation, the cell can no longer prevent tumors from growing, causing an increased risk for cancer.
  • What does BRACAnalysis test for?
    BRACAnalysis tests for a mutation in specific genes to determine hereditary breast or ovarian cancer risk.
  • How will I add genetic testing and screening into my practice?
    Our Myriad Complete program helps physicians incorporate MyRisk into their practice with education, access to genetic products, results delivered, and consults from genetic counselors.
  • What does MyRisk test for?
    MyRisk multi-gene panel determines hereditary cancer risk for: Breast, ovarian, colorectal, endometrial, melanoma, pancreatics, gastric, and prostate cancer.
  • What does the GeneSight test do?
    GeneSight analyzes how genes may affect medication outcomes. Results can inform a physician about how a patient may break down or respond to certain medications commonly prescribed to treat depression, anxiety, ADHD, and other psychiatric conditions.

Any more questions? We are here for you!